# A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

Source: https://onco.cc/trials/nct03776968/  
OnCo record `nct03776968` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of Deutenzalutamide run by Hinova Pharmaceuticals Inc., completed.

## Summary

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics is a phase 1 interventional study registered as NCT03776968 by Hinova Pharmaceuticals Inc., with 47 participants enrolled, started 2017-10-24. Conditions recorded: Metastatic Castration Resistant Prostate Cancer. Interventions recorded: HC1119.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03776968
- Phase: 1
- Setting: A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics in Healthy Chinese Adults
- Sponsor: Hinova Pharmaceuticals Inc.
- Enrolled: 47

## Sources

- ClinicalTrials.gov NCT03776968: https://clinicaltrials.gov/study/NCT03776968

## Connected records

- cancers: [Metastatic castration-resistant prostate cancer](https://onco.cc/cancers/prostate-mcrpc/)
- drugs: [Deutenzalutamide](https://onco.cc/drugs/deutenzalutamide/)
- companies: [Hinova Pharmaceuticals](https://onco.cc/companies/hinova-pharmaceuticals/)

---
JSON: https://onco.cc/api/v1/entities/nct03776968.json